Insider Trading May 4, 2026 07:55 PM

Marcus & Millichap Director Executes Substantial Common Stock Purchase

Amended SEC filings confirm Lauralee Martin's acquisition of 1,701 shares amid recent quarterly earnings volatility.

By Hana Yamamoto MMI
Marcus & Millichap Director Executes Substantial Common Stock Purchase
MMI

An amended regulatory filing has revealed that Lauralee Martin, a Director at Marcus & Millichap, Inc. (NYSE: MMI), expanded her position in the company through a common stock purchase on August 11, 2025. The transaction, which totaled $49,905, was officially disclosed via an amended Form 4 filed with the Securities and Exchange Commission.The details of the acquisition involve the purchase of 1,701 shares at a price point of $29.3388 per share. This transaction brings Ms. Martin's total direct holdings of Marcus & Millichap common stock to 17,728 shares. The disclosure serves as a correction to an earlier report dated August 12, 2025, which contained inaccurate figures regarding both the number of shares acquired and the resulting total beneficial ownership.

Key Points

  • Director Lauralee Martin purchased 1,701 shares of MMI at $29.3388 per share.
  • The company reported a significant EPS beat of 41.67%, delivering $0.34 against a $0.24 forecast.
  • Revenue for the fourth quarter of 2025 was $244 million, missing analyst expectations.

Marcus & Millichap, Inc. (NYSE: MMI) has seen recent activity at the director level following an amended filing with the Securities and Exchange Commission. Lauralee Martin, serving as a Director for the firm, completed a purchase of common stock on August 11, 2025, involving a total investment of $49,905.

According to the amended Form 4/A filing, Ms. Martin acquired 1,701 shares at an individual share price of $29.3388. This transaction results in a direct holding of 17,728 shares for Ms. Martin. The necessity for an amended filing arose to correct data provided in a previous report from August 12, 2025. The initial documentation had incorrectly stated that the acquisition consisted of 1,721 shares and indicated a total beneficial ownership of 17,748 shares. The updated filing clarifies these specific figures for regulatory accuracy.


Key Transactional and Financial Points

The recent activity at Marcus & Millichap can be summarized through several critical data points:

  • Director Investment: Lauralee Martin's purchase of 1,701 shares represents a significant individual stake adjustment during the month of August.
  • Earnings Outperformance: In its fourth-quarter earnings report for 2025, Marcus & Millichap reported an earnings per share (EPS) of $0.34. This figure surpassed analyst expectations of $0.24, representing a positive surprise of 41.67%.
  • Revenue Performance: While earnings exceeded forecasts, the company's revenue for the same period was $244 million, which fell slightly below anticipated levels.

These metrics impact the real estate services sector and broader financial markets by highlighting a divergence between profitability per share and top-line revenue growth.


Risk Factors and Market Uncertainties

Based on the reported data, investors should note the following uncertainties:

  • Revenue Shortfalls: The discrepancy between the company's high earnings surprise and its failure to meet revenue expectations suggests potential volatility in top-line growth trajectories.
  • Reporting Corrections: The requirement for an amended Form 4 filing indicates that initial regulatory disclosures may contain inaccuracies that require subsequent correction.

Such factors can influence investor sentiment within the brokerage and real estate services industries, as market participants weigh strong EPS against missed revenue targets.

Risks

  • Revenue performance fell below forecasted levels, potentially impacting long-term growth perceptions in the real estate services sector.
  • The need for amended SEC filings to correct previous reporting errors regarding share counts and ownership totals.

More from Insider Trading

Bank of Hawaii Director Executes Common Stock Sale Amid Shifting Analyst Outlooks May 4, 2026 Slide Insurance Holdings CFO Executes Stock Sales Amid Recent Earnings Growth May 4, 2026 Slide Insurance CEO Executes $2.87 Million Stock Sale via Pre-Arranged Trading Plan May 4, 2026 Slide Insurance Executive Executes Stock Sales Under Pre-Arranged Plan May 4, 2026 Ligand Pharmaceuticals Executive Executes Rule 10b5-1 Stock Transactions Amid Strategic Portfolio Expansion May 4, 2026